ASM Microbe 2024: How molecular diagnostic tests can inform clinical decision-making

Attendees at the American Society for Microbiology (ASM) Microbe 2024 in Atlanta, Georgia are invited to view three posters presented by Microbio Founder and Chief Scientific Officer, Dr Flavia Huygens. If you’re curious about the power of molecular diagnostics to support clinical decision-making in sepsis, a discussion with Dr Huygens is highly recommended!

💡Friday 14 June: InfectID-BSI—A rapid and quantitative aPCR test impacting on clinical management of bloodstream infections / sepsis caused by Enterobacter cloacae (CPHM-Friday-292)

đź’ˇSaturday 15 June: Whole blood qPCR detection and quantitation of Streptococcus pneumoniae challenges clinicians and medical microbiologists to reconsider sepsis management (CPHM-Saturday-302)

💡Sunday 16 June: Quantitative PCR—A novel clinical tool for patients with bloodstream infections (CPHM-Sunday-326)